Literature DB >> 12472547

Mechanisms of desmosome assembly and disassembly.

Y Kitajima1.   

Abstract

In skin, desmosomes constitute critical adhesion complexes between adjacent keratinocytes that help maintain an intact epidermis. However, individual keratinocytes need to migrate and differentiate and therefore desmosomes must have an inherent dynamic capacity to assemble and disassemble. This review highlights the role of the different structural junctional components involved in desmosome formation and turnover, as well as the possible signalling processes and pathways that may be implicated in desmosome homeostasis. Clues to the intricate nature of desmosome assembly and disassembly have been derived from human inherited and acquired blistering skin diseases as well as animal models and basic cell biology studies. The key implications for understanding desmosome dynamics from these findings are summarized in this review.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12472547     DOI: 10.1046/j.1365-2230.2002.01116.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  15 in total

1.  Plakoglobin rescues adhesive defects induced by ectodomain truncation of the desmosomal cadherin desmoglein 1: implications for exfoliative toxin-mediated skin blistering.

Authors:  Cory L Simpson; Shin-ichiro Kojima; Victoria Cooper-Whitehair; Spiro Getsios; Kathleen J Green
Journal:  Am J Pathol       Date:  2010-11-12       Impact factor: 4.307

2.  Co-regulation of p16INK4A and migratory genes in culture conditions that lead to premature senescence in human keratinocytes.

Authors:  Benjamin W Darbro; Galen B Schneider; Aloysius J Klingelhutz
Journal:  J Invest Dermatol       Date:  2005-09       Impact factor: 8.551

Review 3.  Darier's disease: a calcium-signaling perspective.

Authors:  B Pani; B B Singh
Journal:  Cell Mol Life Sci       Date:  2008-01       Impact factor: 9.261

4.  Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction.

Authors:  Jens Waschke; Paola Bruggeman; Werner Baumgartner; Detlef Zillikens; Detlev Drenckhahn
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

5.  Desmosome disassembly in response to pemphigus vulgaris IgG occurs in distinct phases and can be reversed by expression of exogenous Dsg3.

Authors:  Jean M Jennings; Dana K Tucker; Margaret D Kottke; Masataka Saito; Emmanuella Delva; Yasushi Hanakawa; Masayuki Amagai; Andrew P Kowalczyk
Journal:  J Invest Dermatol       Date:  2010-12-16       Impact factor: 8.551

Review 6.  A perspective of pemphigus from bedside and laboratory-bench.

Authors:  Yasuo Kitajima; Yumi Aoyama
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

7.  Hepatitis C virus-like particle budding: role of the core protein and importance of its Asp111.

Authors:  Emmanuelle Blanchard; Christophe Hourioux; Denys Brand; Malika Ait-Goughoulte; Alain Moreau; Sylvie Trassard; Pierre-Yves Sizaret; Frederic Dubois; Philippe Roingeard
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Disruption of desmosome assembly by monovalent human pemphigus vulgaris monoclonal antibodies.

Authors:  Xuming Mao; Eun Jung Choi; Aimee S Payne
Journal:  J Invest Dermatol       Date:  2008-11-27       Impact factor: 8.551

9.  MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris.

Authors:  Xuming Mao; Hong Li; Yasuyo Sano; Matthias Gaestel; Jin Mo Park; Aimee S Payne
Journal:  J Invest Dermatol       Date:  2013-06-27       Impact factor: 8.551

10.  Pemphigus vulgaris autoantibody profiling by proteomic technique.

Authors:  Mina Kalantari-Dehaghi; Grant J Anhalt; Michael J Camilleri; Alex I Chernyavsky; Sookhee Chun; Philip L Felgner; Algis Jasinskas; Kristin M Leiferman; Li Liang; Steve Marchenko; Rie Nakajima-Sasaki; Mark R Pittelkow; John J Zone; Sergei A Grando
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.